The DOI matches its Crossref record.
Apligraf in the Treatment of Neuropathic Diabetic Foot Ulcers
Abstract
This study compared the efficacy and safety of Apligraf (Organogenesis, Inc., Canton, MA) in combination with standard therapy versus standard therapy alone in the treatment of neuropathic diabetic foot ulcers. Efficacy was assessed by time to complete wound healing (by 12 weeks) and incidence of complete wound closure (at 12 weeks). This was an international multi-center, randomized, controlled study. Patients were eligible for entry into the study if the following criteria were met: type 1 or type 2 diabetes mellitus, age 18 to 80 years, adequate glycemic control, and the presence of a full-thickness neuropathic ulcer for at least 2 weeks prior to the initial screening visit. Following the 2-week screening period, the 2 treatment groups received standard ulcer care consistent with international treatment guidelines that comprised sharp debridement, saline-moistened dressings, and a non—weight bearing regimen. There were 106 subjects screened for enrollment, 82 randomized to the treatment groups, and 72 treated (33 Apligraf subjects and 39 standard therapy subjects) before the study was terminated. Kaplan—Meier curves indicated a trend for shorter time to complete wound healing in the Apligraf group compared with the standard therapy group ( p = .059; log-rank test). The median time to healing was 84 days in the Apligraf group, whereas no median time to healing could be determined for the standard therapy group because <50% of the standard therapy subjects healed. By 12 weeks, 51.5% (17/33) Apligraf subjects had achieved complete wound closure compared with 26.3% (10/38) of standard therapy subjects ( p = .049; Fisher's exact test). Even though the study was halted prematurely, this study suggested that the use of Apligraf resulted in a higher incidence of wound closure by 12 weeks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Collagen-Based Biomaterials for Tissue Engineering Applications
Parenteau-Bareil, R., Gauvin, R., & Berthod, F. (2010) · Materials · doi:10.3390/ma3031863 · Cited by 1,256
Advanced drug delivery systems and artificial skin grafts for skin wound healing
Kim, H. S., Sun, X., Lee, J.-H., Kim, H.-W., Fu, X., & Leong, K. W. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.014 · Cited by 625
Literature review on the management of diabetic foot ulcer
Yazdanpanah, L. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i1.37 · Cited by 596
Mondal, D., Griffith, M., & Venkatraman, S. S. (2016) · International Journal of Polymeric Materials and Polymeric Biomaterials · doi:10.1080/00914037.2015.1103241 · Cited by 515
Böttcher-Haberzeth, S., Biedermann, T., & Reichmann, E. (2010) · Burns · doi:10.1016/j.burns.2009.08.016 · Cited by 359
Metadata
- Authors
- Edmonds, M., & European and Australian Apligraf Diabetic Foot Ulcer Study Group
- Venue
- The International Journal of Lower Extremity Wounds
- Publisher
- SAGE Publications
- Published
- 2009-02-03
- Volume
- 8
- Issue
- 1
- Pages
- 11-18
- ISSN
- 1534-7346 (ISSN-L)
- 1552-6941
- OpenAlex
- W2060307603
- Cited by
- 195
- References
- 0
- FWCI
- 6.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Apligraf in the Treatment of Neuropathic Diabetic Foot Ulcers. https://app.cochat.ai/papers/10.1177/1534734609331597
- The paper
- Edmonds, M., & European and Australian Apligraf Diabetic Foot Ulcer Study Group. (2009). Apligraf in the Treatment of Neuropathic Diabetic Foot Ulcers. The International Journal of Lower Extremity Wounds. https://doi.org/10.1177/1534734609331597
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.